How to Help Your Patients Find Triamcinolone in Stock: A Provider's Guide

With triamcinolone acetonide injectable suspension in active shortage since mid-2025, many providers are fielding calls from frustrated patients who cannot fill their prescriptions. This guide provides a practical workflow for your practice — covering what to tell patients, how to prescribe around the shortage, and how to use pharmacy search tools to reduce patient burden and call volume to your office.

Step 1: Understand Which Formulations Are Affected

Not all triamcinolone forms are equal in terms of shortage impact. Your approach to helping patients will depend on what they were prescribed:

Injectable suspension (40 mg/mL): Active national shortage. Multiple manufacturers affected simultaneously. Most difficult to source.

Topical cream/ointment (0.025%, 0.1%, 0.5%): Generally available at most retail pharmacies. Patients may need to call ahead or try a different pharmacy for higher strengths.

Nasacort nasal spray (OTC): Widely available OTC. Patients should be able to pick this up without a prescription at most pharmacies.

Dental paste (Oralone): May require pharmacy ordering ahead; sporadic availability depending on distributor.

Step 2: Provide a Practical Script for Your Front Desk

When patients call saying they cannot fill their triamcinolone injection prescription, equip your front desk with a clear protocol. A sample script:

"Triamcinolone injection is in a national shortage right now, and many pharmacies are out of stock. We have a few options: (1) we can try to locate a pharmacy near you using a pharmacy finder service, (2) we can check if you are eligible for an alternative injectable like methylprednisolone at your next appointment, or (3) we can see if a compounding pharmacy can prepare the medication. Which would you prefer to explore?"

Step 3: Use medfinder to Find Pharmacies in Stock

Rather than asking your staff to manually call pharmacies, medfinder for Providers can handle the pharmacy search on behalf of your patient. The service calls pharmacies near the patient's zip code and texts the patient a list of locations where their prescription can be filled. This reduces inbound calls to your office and lets your clinical staff focus on care rather than logistics.

Step 4: Know When to Write for an Alternative

When the injectable is needed immediately and cannot be sourced, these alternatives are appropriate for most indications:

For joint injections (OA, RA, bursitis): Methylprednisolone acetate 40 mg/mL (Depo-Medrol). Note: risk of crystal-related post-injection flare may be marginally higher.

For intralesional use: Diluting available 40 mg/mL triamcinolone to 10 mg/mL, or using compounded triamcinolone.

For IM depot (allergy/systemic): Betamethasone 6 mg IM or methylprednisolone 80 mg IM depending on clinical context.

For topical skin conditions: If topical triamcinolone is unavailable at patient's pharmacy, mometasone furoate 0.1% or betamethasone valerate 0.1% are comparable alternatives.

Step 5: Consider Compounding for Injectable Formulations

A 503A or 503B compounding pharmacy can prepare triamcinolone acetonide injectable suspension using pharmaceutical-grade bulk active ingredients when commercially manufactured product is unavailable. For 503B outsourcing facilities, the product may be available in bulk for your practice's in-office supply. A specific compounding prescription is required from you — contact your local compounding pharmacy to understand their capabilities and required paperwork.

Step 6: Document the Shortage Substitution

When you substitute an alternative corticosteroid due to triamcinolone unavailability, document this clearly in the patient's chart:

Note the reason for substitution (drug shortage)

Record the agent used, dose, and administration site

Note patient tolerance and any adverse effects at next visit

For a full clinical briefing including all manufacturer statuses, see: Triamcinolone Shortage: What Providers and Prescribers Need to Know in 2026.